Gao, D., Shi, Y., Wang, Z., & Liu, W. FDA-approved kinase inhibitors: A promising therapeutic avenue for traumatic brain injury. Open Exploration.
Chicago Style (17th ed.) CitationGao, Dezhu, Yu Shi, Zhiliang Wang, and Weiming Liu. FDA-approved Kinase Inhibitors: A Promising Therapeutic Avenue for Traumatic Brain Injury. Open Exploration.
MLA (9th ed.) CitationGao, Dezhu, et al. FDA-approved Kinase Inhibitors: A Promising Therapeutic Avenue for Traumatic Brain Injury. Open Exploration.
Warning: These citations may not always be 100% accurate.